{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:43:52Z","timestamp":1789393432604,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"am","delay-in-days":428,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K07CA201013"],"award-info":[{"award-number":["K07CA201013"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32CA101642"],"award-info":[{"award-number":["T32CA101642"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ygyno.2024.01.039","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T15:48:07Z","timestamp":1708098487000},"page":"120-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center"],"prefix":"10.1016","volume":"183","author":[{"given":"Anne","family":"Knisely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria D.","family":"Iniesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Batman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa A.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela T.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Cain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Marten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Schmeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolyn S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole D.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2024.01.039_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11239-015-1311-6","article-title":"The epidemiology of venous thromboembolism","volume":"41","author":"Heit","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"issue":"10","key":"10.1016\/j.ygyno.2024.01.039_bb0010","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3390\/cancers14102439","article-title":"A systematic review of the guidelines on venous thromboembolism prophylaxis in gynecologic oncology","volume":"14","author":"Romano","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ygyno.2024.01.039_bb0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ygyno.2007.03.004","article-title":"Venous thromboembolism prevention in gynecologic cancer surgery: a systematic review","volume":"105","author":"Einstein","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.039_bb0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.thromres.2020.09.019","article-title":"The risk factors for perioperative venous thromboembolism in patients with gynecological malignancies: a meta-analysis","volume":"196","author":"Ma","year":"2020","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.ygyno.2024.01.039_bb0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejogrb.2009.03.012","article-title":"Deep venous thrombosis in gynecological oncology: incidence and clinical symptoms study","volume":"144","author":"Santoso","year":"2009","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"9","key":"10.1016\/j.ygyno.2024.01.039_bb0030","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1097\/IGC.0b013e3182a80aa7","article-title":"Incidence and predictors of venous thromboembolism after debulking surgery for epithelial ovarian cancer","volume":"23","author":"Mokri","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2024.01.039_bb0035","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1245\/s10434-016-5127-1","article-title":"Role of extended Thromboprophylaxis after abdominal and pelvic surgery in Cancer patients: a systematic review and Meta-analysis","volume":"23","author":"Fagarasanu","year":"2016","journal-title":"Ann. Surg. Oncol."},{"issue":"13","key":"10.1016\/j.ygyno.2024.01.039_bb0040","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa012385","article-title":"Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer","volume":"346","author":"Bergqvist","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2024.01.039_bb0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with Cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"2 Suppl","key":"10.1016\/j.ygyno.2024.01.039_bb0050","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.1412S3","article-title":"American College of Chest Physicians Antithrombotic Therapy and Prevention of thrombosis panel. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest."},{"issue":"2","key":"10.1016\/j.ygyno.2024.01.039_bb0055","doi-asserted-by":"crossref","first-page":"140.e1","DOI":"10.1016\/j.ajog.2023.04.045","article-title":"Rate of venous thromboembolism on an enhanced recovery program after gynecologic surgery","volume":"229","author":"Taylor","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.01.039_bb0060","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ygyno.2012.11.027","article-title":"Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies","volume":"128","author":"Schmeler","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.039_bb0065","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2021.01.027","article-title":"Prevention of venous thromboembolism in gynecological cancer patients undergoing major abdominopelvic surgery: a systematic review and network meta-analysis","volume":"161","author":"Insin","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.01.039_bb0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3928\/0147-7447-20050201-16","article-title":"Patient compliance with outpatient prophylaxis: an observational study","volume":"28","author":"Colwell","year":"2005","journal-title":"Orthopedics."},{"issue":"26","key":"10.1016\/j.ygyno.2024.01.039_bb0075","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1006885","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after hip replacement","volume":"363","author":"Lassen","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9717","key":"10.1016\/j.ygyno.2024.01.039_bb0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(09)62125-5","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial","volume":"375","author":"Lassen","year":"2010","journal-title":"Lancet."},{"issue":"6","key":"10.1016\/j.ygyno.2024.01.039_bb0085","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s11605-018-3936-1","article-title":"Dabigatran (Pradaxa) is safe for extended venous thromboembolism prophylaxis after surgery for pancreatic cancer","volume":"23","author":"Rashid","year":"2019","journal-title":"J. Gastrointest. Surg."},{"issue":"6","key":"10.1016\/j.ygyno.2024.01.039_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7410","article-title":"Safety and efficacy of Apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant neoplasm: a randomized clinical trial","volume":"3","author":"Guntupalli","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.039_bb0095","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ygyno.2020.11.020","article-title":"Direct oral anticoagulant use in gynecologic oncology: a society of gynecologic oncology clinical practice statement","volume":"160","author":"Gressel","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.039_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2023.02.012","article-title":"Apixaban for extended postoperative thromboprophylaxis in gynecologic oncology patients undergoing laparotomy","volume":"172","author":"Sp\u00e9nard","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.039_bb0105","author":"Venous Thromboembolism (VTE) Prophylaxis for Adult Patients"},{"issue":"6","key":"10.1016\/j.ygyno.2024.01.039_bb0110","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/jth.13323","article-title":"Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH","volume":"14","author":"Martin","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"02","key":"10.1016\/j.ygyno.2024.01.039_bb0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-0041-1723952","article-title":"Direct Oral anticoagulants in the treatment of venous thromboembolism: use in patients with advanced renal impairment, obesity, or other weight-related special populations","volume":"42","author":"Dobesh","year":"2021","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.ygyno.2024.01.039_bb0120","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.ygyno.2024.01.039_bb0125","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.ygyno.2024.01.039_bb0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0895-4356(02)00585-1","article-title":"How to measure comorbiditya critical review of available methods","volume":"56","author":"Degroot","year":"2003","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ygyno.2024.01.039_bb0135","author":"Statement on ASA Physical Status Classification System"},{"issue":"7","key":"10.1016\/j.ygyno.2024.01.039_bb0140","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0959-8049(95)00664-8","article-title":"Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution","volume":"32A","author":"Buccheri","year":"1996","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2024.01.039_bb0145","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ygyno.2015.07.017","article-title":"Effectiveness and safety of expanded perioperative thromboprophylaxis in complex gynecologic surgery","volume":"138","author":"Corr","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2024.01.039_bb0150","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/bcp.12114","article-title":"Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects","volume":"76","author":"Upreti","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.ygyno.2024.01.039_bb0155","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/jth.15358","article-title":"Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: updated communication from the ISTH SSC subcommittee on control of anticoagulation","volume":"19","author":"Martin","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.ygyno.2024.01.039_bb0160","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1177\/1060028020923584","article-title":"Direct Oral anticoagulants in obesity: an updated literature review","volume":"54","author":"Sebaaly","year":"2020","journal-title":"Ann. Pharmacother."},{"issue":"2","key":"10.1016\/j.ygyno.2024.01.039_bb0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/phar.2655","article-title":"Multi-center retrospective study evaluating the efficacy and safety of apixaban versus warfarin for treatment of venous thromboembolism in patients with severe obesity","volume":"42","author":"Crouch","year":"2022","journal-title":"Pharmacotherapy."},{"issue":"6","key":"10.1016\/j.ygyno.2024.01.039_bb0170","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40256-022-00524-x","article-title":"Apixaban use in obese patients: a review of the pharmacokinetic, interventional, and observational study data","volume":"22","author":"Jamieson","year":"2022","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"2","key":"10.1016\/j.ygyno.2024.01.039_bb0175","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2020.07.096","article-title":"Cost-effectiveness of apixaban for prevention of venous thromboembolic events in patients after gynecologic cancer surgery","volume":"159","author":"Glickman","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.039_bb0180","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619849103","article-title":"Cost-effectiveness evaluations among the direct Oral anticoagulants for the prevention and treatment of venous thromboembolism: systematic review","volume":"25","author":"Al Mukdad","year":"2019","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"46","key":"10.1016\/j.ygyno.2024.01.039_bb0185","article-title":"Anthropometric reference data for children and adults: United States, 2015\u20132018","volume":"3","author":"Fryar","year":"2021","journal-title":"Vital Health Stat."},{"issue":"4","key":"10.1016\/j.ygyno.2024.01.039_bb0190","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/JU.0000000000002788","article-title":"Apixaban vs enoxaparin for post-surgical extended-duration venous thromboembolic event prophylaxis: a prospective quality improvement study","volume":"208","author":"Westerman","year":"2022","journal-title":"J. Urol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824000659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824000659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:58:09Z","timestamp":1777474689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824000659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":38,"alternative-id":["S0090825824000659"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.039","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}